Close
Courage over Cancer Filtered Blog
Breast cancer research with global impact
BRCA1 and BRCA2 are genes that help protect the body by fixing damaged DNA and keeping cells healthy. When these genes have changes, or mutations, they don’t work the way they should. This can raise the risk of certain cancers, like breast, ovarian, prostate and pancreatic cancer. These inherited mutations affect about 1 in every 200 to 300 people — over a million in the U.S. alone.
Read more
Texas Public Radio: The importance of getting screened for colon cancer
Alicia Logue, MD, associate professor, Department of Surgery, was interviewed for this episode of The Source. Listen Now
Read morePromising cancer researcher, Falzone, receives UT System Rising STARs award
Maria E. Falzone, PhD, assistant professor in the Department of Biochemistry and Structural Biology in the Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), has received a $150,000 UT Science and Technology Acquisition and Retention (STARs) award from the […]
Read moreTargeted drug offers hope for safe, effective senolytic treatment for liver disease, cancer
San Antonio has one of the highest rates of metabolic dysfunction-associated steatotic liver disease (MASLD) in the United States, largely driven by high rates of obesity and diabetes in the region. This chronic liver condition can lead to serious health conditions including severe liver fibrosis or cirrhosis and liver cancer, posing a significant public health […]
Read more
CPRIT awards UT Health San Antonio $3.2 million to accelerate cancer research, launch novel clinical trial
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) received more than $3.19 million in new academic research awards as part of the latest $68 million funding round announced on February 19 by the Cancer Research Prevention Institute of Texas (CPRIT). The state agency, which focuses on the fight […]
Read moreCracking cancer’s code: New research identifies novel drug target for acute myeloid leukemia treatment
Despite advances in cancer treatment in recent years, five-year survival rates for acute myeloid leukemia (AML) remain low at just 30% on average, according to the National Cancer Institute. Factors in the development of AML are diverse with many different drivers. A longtime goal for scientists in this field is finding a single drug that can treat all types of AML.
Read more
New book provides big recommendations from the Advancing the Science of Cancer in Latinos Conference
Research findings, strategies target the leading cause of Latino death With cancer still rising in the U.S. Latino population, leaders at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and national cancer experts have published an online book with innovative recommendations to reduce Latino cancer. The book, “Advancing the […]
Read more
Renowned oncologist, Zheng, brings $500,000 UT System STARs award to UT Health San Antonio
Lei Zheng, MD, PhD, executive director of the Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), has been awarded a $500,000 Translational Science and Technology Acquisition and Retention (STARs) award from The University of Texas System to elevate his research into monitoring pancreatic tumor […]
Read moreWhere tomorrow’s breakthroughs begin: UT Health San Antonio’s first hospital opens, merging comprehensive care, innovation
This article is featured in the December 2024 issue of San Antonio Medicine Magazine. As the golden sun peeks over the Hill Country skyline, UT Health San Antonio Multispecialty and Research Hospital begins to stir with the promise of a new day. A physician-scientist steps purposefully through the sleek glass entrance into an atrium bathed […]
Read moreTwo UT Health San Antonio scientists awarded V Foundation grants to advance innovative cancer research
This year in the United States, it is projected that more than 2 million people will be diagnosed with cancer. Additionally, more than 600,000 people will die of the disease — an average of nearly 1,680 each day. The V Foundation for Cancer Research was founded in 1993 by ESPN and basketball coach Jim Valvano […]
Read moreLife, legacy of 2024 Basser Global Prize winner Patrick Sung
World-renowned biochemist and expert on the roles of BRCA1 and BRCA 2 in DNA repair, Patrick Sung, DPhil, director of the Greehey Children’s Cancer Research Institute and associate dean for research at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was recently recognized as the 2024 recipient of the […]
Read more
Center for Pain Therapeutics and Addiction Research earns first NIH grant
The School of Dentistry earned the first National Institutes of Health grant under its new Center for Pain Therapeutics and Addiction Research, addressing pain in patients with head and neck carcinoma.
Read more
UT Health San Antonio world-renowned expert in BRCA research to be honored for global contributions
Patrick Sung, DPhil, director of the Greehey Children’s Cancer Research Institute and associate dean for research at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) is the latest recipient of the 2024 Basser Global Prize. A leading researcher in the field of DNA damage repair and cancer biology, Sung has been awarded the […]
Read more
Mays Cancer Center radiation oncologist recognized as outstanding mentor to next generation leaders
David Gius, MD, PhD, professor in the Department of Radiation Oncology and assistant dean of research at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), was named this year’s recipient of the prestigious American Society for Radiation Oncology (ASTRO) Career Recognition Mentorship Award. David Gius, MD, PhD Gius is associate cancer center director […]
Read more
Game-changing prostate cancer treatment available at UT Health San Antonio
One in eight men will develop prostate cancer in their lifetime. Of those, one in 44 men will die of the disease. Those statistics from the American Cancer Society are startling. But men facing an advanced prostate cancer diagnosis who are seeking additional treatment options now have one more arrow in their quiver to […]
Read more
Oral health’s hidden role in cancer care
Dental care is crucial for cancer patients and survivors to help reduce complications, improve treatment tolerance and enhance overall quality of life, according to oral medicine specialist Tiffany Tavares, DDS, DMSc.
Read more
Henrich, new hospital supporters recognized at Luminary event
The stars aligned perfectly during a night of celebration at the second annual President’s Luminary Honors event at The University of Texas Health Science Center at San Antonio. The annual event, which took place at the soon-to-open UT Health San Antonio Multispecialty and Research Hospital, paid tribute to the legacy of William L. Henrich, […]
Read more
Renowned cancer researcher brings $500,000 UT System Faculty STARs award to UT Health San Antonio
Simon Gayther, PhD, professor of medicine in the Division of Hematology and Oncology in the Joe R. and Teresa Lozano Long School of Medicine and founding director in the school’s Center for Inherited Oncogenesis at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), received a $500,000 UT System […]
Read more